Viewing Study NCT00550420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-03-04 @ 7:02 AM
Study NCT ID: NCT00550420
Status: TERMINATED
Last Update Posted: 2017-11-08
First Post: 2007-10-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None open-label extension View
None tolerability View
None Alzheimer's disease View
None Rosiglitazone extended-release (XR) View
None safety View
None cognition View
None BRL-049653 View